249 related articles for article (PubMed ID: 36884303)
21. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698
[TBL] [Abstract][Full Text] [Related]
22. Cilostazol-mediated reversion of γ-globin silencing is associated with a high level of HbF production: A potential therapeutic candidate for β-globin disorders.
Ali H; Khan F; Musharraf SG
Biomed Pharmacother; 2021 Oct; 142():112058. PubMed ID: 34426256
[TBL] [Abstract][Full Text] [Related]
23. Quantification of HBG mRNA in primary erythroid cultures: prediction of the response to hydroxyurea in sickle cell and beta-thalassemia.
Pecoraro A; Rigano P; Troia A; Calzolari R; Scazzone C; Maggio A; Steinberg MH; Di Marzo R
Eur J Haematol; 2014 Jan; 92(1):66-72. PubMed ID: 24112139
[TBL] [Abstract][Full Text] [Related]
24. Role of microRNA in hydroxyurea mediated HbF induction in sickle cell anaemia patients.
Kargutkar N; Sawant-Mulay M; Hariharan P; Chandrakala S; Nadkarni A
Sci Rep; 2023 Jan; 13(1):369. PubMed ID: 36611033
[TBL] [Abstract][Full Text] [Related]
25. S110, a novel decitabine dinucleotide, increases fetal hemoglobin levels in baboons (P. anubis).
Lavelle D; Saunthararajah Y; Vaitkus K; Singh M; Banzon V; Phiasivongsva P; Redkar S; Kanekal S; Bearss D; Shi C; Inloes R; DeSimone J
J Transl Med; 2010 Oct; 8():92. PubMed ID: 20932295
[TBL] [Abstract][Full Text] [Related]
26. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
Rodgers GP
Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375
[TBL] [Abstract][Full Text] [Related]
27. Determinants of fetal hemoglobin response to hydroxyurea.
Steinberg MH
Semin Hematol; 1997 Jul; 34(3 Suppl 3):8-14. PubMed ID: 9317196
[TBL] [Abstract][Full Text] [Related]
28. Association between BCL11A, HSB1L-MYB, and XmnI γG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
El-Ghamrawy M; Yassa ME; Tousson AMS; El-Hady MA; Mikhaeil E; Mohamed NB; Khorshied MM
Ann Hematol; 2020 Oct; 99(10):2279-2288. PubMed ID: 32772141
[TBL] [Abstract][Full Text] [Related]
29. Induction of fetal hemoglobin in the treatment of sickle cell disease.
Fathallah H; Atweh GF
Hematology Am Soc Hematol Educ Program; 2006; ():58-62. PubMed ID: 17124041
[TBL] [Abstract][Full Text] [Related]
30. The cellular basis for different fetal hemoglobin levels among sickle cell individuals with two, three, and four alpha-globin genes.
Dover GJ; Chang VT; Boyer SH; Serjeant GR; Antonarakis S; Higgs DR
Blood; 1987 Jan; 69(1):341-4. PubMed ID: 2431731
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological Induction of Human Fetal Globin Gene in Hydroxyurea-Resistant Primary Adult Erythroid Cells.
Chou YC; Chen RL; Lai ZS; Song JS; Chao YS; Shen CK
Mol Cell Biol; 2015 Jul; 35(14):2541-53. PubMed ID: 25986606
[TBL] [Abstract][Full Text] [Related]
32. Hydroxymethylcytosine and demethylation of the γ-globin gene promoter during erythroid differentiation.
Ruiz MA; Rivers A; Ibanez V; Vaitkus K; Mahmud N; DeSimone J; Lavelle D
Epigenetics; 2015; 10(5):397-407. PubMed ID: 25932923
[TBL] [Abstract][Full Text] [Related]
33. miRNA Expression Associated with HbF in Saudi Sickle Cell Anemia.
Cyrus C; Vatte C; Al-Nafie A; Chathoth S; Akhtar MS; Darwish M; Almohazey D; AlDubayan SH; Steinberg MH; Al-Ali A
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295630
[No Abstract] [Full Text] [Related]
34. Genetic modifiers of HbF and response to hydroxyurea in sickle cell disease.
Green NS; Barral S
Pediatr Blood Cancer; 2011 Feb; 56(2):177-81. PubMed ID: 20830771
[TBL] [Abstract][Full Text] [Related]
35. A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition.
Traxler EA; Yao Y; Wang YD; Woodard KJ; Kurita R; Nakamura Y; Hughes JR; Hardison RC; Blobel GA; Li C; Weiss MJ
Nat Med; 2016 Sep; 22(9):987-90. PubMed ID: 27525524
[TBL] [Abstract][Full Text] [Related]
36. Tenofovir disoproxil fumarate induces fetal hemoglobin production in K562 cells and β-YAC transgenic mice: A therapeutic approach for γ-globin induction.
Khan F; Ali H; Musharraf SG
Exp Cell Res; 2020 Sep; 394(2):112168. PubMed ID: 32653411
[TBL] [Abstract][Full Text] [Related]
37. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing.
Xu J; Peng C; Sankaran VG; Shao Z; Esrick EB; Chong BG; Ippolito GC; Fujiwara Y; Ebert BL; Tucker PW; Orkin SH
Science; 2011 Nov; 334(6058):993-6. PubMed ID: 21998251
[TBL] [Abstract][Full Text] [Related]
38. Fetal hemoglobin induction by acetate, a product of butyrate catabolism.
Stamatoyannopoulos G; Blau CA; Nakamoto B; Josephson B; Li Q; Liakopoulou E; Pace B; Papayannopoulou T; Brusilow SW; Dover G
Blood; 1994 Nov; 84(9):3198-204. PubMed ID: 7524768
[TBL] [Abstract][Full Text] [Related]
39. Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex.
Charache S; Dover G; Smith K; Talbot CC; Moyer M; Boyer S
Proc Natl Acad Sci U S A; 1983 Aug; 80(15):4842-6. PubMed ID: 6192443
[TBL] [Abstract][Full Text] [Related]
40. Understanding heterogeneity of fetal hemoglobin induction through comparative analysis of F and A erythroblasts.
Khandros E; Huang P; Peslak SA; Sharma M; Abdulmalik O; Giardine BM; Zhang Z; Keller CA; Hardison RC; Blobel GA
Blood; 2020 May; 135(22):1957-1968. PubMed ID: 32268371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
